Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观察析滤过(HDF)及析(HD)对尿毒症脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有析和腹膜析两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察析滤过(HDF)对老年析患者心管稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：解析和尿毒症对肿瘤标志物水平的影响。

Objective To evaluate the incidence of depress in hemodia lysis and peritoneal dialysis uremia patients.

目的 评价进行析和腹膜析治疗的尿毒症患 者抑郁症的发病情况。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例造管内瘘行析的患者,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠症患者如果利尿效果不佳或合并有心力衰竭或高容量时,可以考虑析治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高对长期析患者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出热病急性肾衰少尿期预后的因素及析在出热病中的应时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观察肾康注射治疗慢性肾功能衰竭的疗效,为控制慢性肾衰患者肾衰进程而延缓进行析提供一个好的方法。